Literature DB >> 19121811

All LQT3 patients need an ICD: true or false?

Peter J Schwartz1, Carla Spazzolini, Lia Crotti.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19121811     DOI： 10.1016/j.hrthm.2008.10.017

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN： 1547-5271            Impact factor:   6.343


× No keyword cloud information.
  17 in total

1.  [The ICD as primary prevention. Rare indications].

Authors:  K Wasmer; J Köbe; C Pott; L Eckardt
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2010-06

2.  Ranolazine for Congenital Long-QT Syndrome Type III: Experimental and Long-Term Clinical Data.

Authors:  Ehud Chorin; Dan Hu; Charles Antzelevitch; Aviram Hochstadt; Luiz Belardinelli; David Zeltser; Hector Barajas-Martinez; Uri Rozovski; Raphael Rosso; Arnon Adler; Jesaia Benhorin; Sami Viskin
Journal:  Circ Arrhythm Electrophysiol       Date:  2016-10

Review 3.  Rationale and objectives for ECG screening in infancy.

Authors:  J Philip Saul; Peter J Schwartz; Michael J Ackerman; John K Triedman
Journal:  Heart Rhythm       Date:  2014-09-18       Impact factor: 6.343

Review 4.  Long-QT syndrome: from genetics to management.

Authors:  Peter J Schwartz; Lia Crotti; Roberto Insolia
Journal:  Circ Arrhythm Electrophysiol       Date:  2012-08-01

5.  Clinical Aspects of Type 3 Long-QT Syndrome: An International Multicenter Study.

Authors:  Arthur A M Wilde; Arthur J Moss; Elizabeth S Kaufman; Wataru Shimizu; Derick R Peterson; Jesaia Benhorin; Coeli Lopes; Jeffrey A Towbin; Carla Spazzolini; Lia Crotti; Wojciech Zareba; Ilan Goldenberg; Jørgen K Kanters; Jennifer L Robinson; Ming Qi; Nynke Hofman; David J Tester; Connie R Bezzina; Marielle Alders; Takeshi Aiba; Shiro Kamakura; Yoshihiro Miyamoto; Mark L Andrews; Scott McNitt; Bronislava Polonsky; Peter J Schwartz; Michael J Ackerman
Journal:  Circulation       Date:  2016-08-26       Impact factor: 29.690

Review 6.  Impact of genetics on the clinical management of channelopathies.

Authors:  Peter J Schwartz; Michael J Ackerman; Alfred L George; Arthur A M Wilde
Journal:  J Am Coll Cardiol       Date:  2013-05-15       Impact factor: 24.094

Review 7.  Inherited cardiac arrhythmias.

Authors:  Peter J Schwartz; Michael J Ackerman; Charles Antzelevitch; Connie R Bezzina; Martin Borggrefe; Bettina F Cuneo; Arthur A M Wilde
Journal:  Nat Rev Dis Primers       Date:  2020-07-16       Impact factor: 52.329

8.  Mutation-specific risk in two genetic forms of type 3 long QT syndrome.

Authors:  Judy F Liu; Arthur J Moss; Christian Jons; Jesaia Benhorin; Peter J Schwartz; Carla Spazzolini; Lia Crotti; Michael J Ackerman; Scott McNitt; Jennifer L Robinson; Ming Qi; Ilan Goldenberg; Wojciech Zareba
Journal:  Am J Cardiol       Date:  2010-01-15       Impact factor: 2.778

9.  Pharmacological and non-pharmacological management of the congenital long QT syndrome: the rationale.

Authors:  Peter J Schwartz
Journal:  Pharmacol Ther       Date:  2011-03-17       Impact factor: 12.310

10.  Next generation diagnostics in inherited arrhythmia syndromes : a comparison of two approaches.

Authors:  James S Ware; Shibu John; Angharad M Roberts; Rachel Buchan; Sungsam Gong; Nicholas S Peters; David O Robinson; Anneke Lucassen; Elijah R Behr; Stuart A Cook
Journal:  J Cardiovasc Transl Res       Date:  2012-09-07       Impact factor: 4.132
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.